Bacterial proteins, enzymes, and cell wall components

Bacterial proteins, enzymes, and cell wall components represent a broad class of therapeutic targets essential for the survival and proliferation of pathogenic bacteria. These targets include structural elements like the peptidoglycan cell wall, which maintains osmotic stability, and vital enzymes such as DNA gyrase and RNA polymerase that facilitate genetic processing [1][2]. Additionally, the bacterial ribosome serves as a primary site for protein synthesis inhibition by various antibiotic classes [3]. Because these structures are often unique to prokaryotes or significantly different from their eukaryotic counterparts, they allow for selective toxicity in treating bacterial infections [4]. However, the clinical utility of drugs hitting these targets is frequently compromised by the emergence of resistance mechanisms, including target mutations and the production of neutralizing enzymes like beta-lactamases [5]. Understanding the diversity of these targets is critical for developing novel antimicrobial strategies to address the global threat of multi-drug resistant organisms [4][5]. Citations: [1] Silhavy, T. J., et al. (2010) Cold Spring Harb Perspect Biol; [2] Bush, K., & Bradford, P. A. (2016) Cold Spring Harb Perspect Med; [3] Wilson, D. N. (2014) Nat Rev Microbiol; [4] Kapoor, G., et al. (2017) J Clin Diagn Res; [5] Blair, J. M., et al. (2015) Nat Rev Microbiol.

Other names

Bacterial molecular targetsProkaryotic targetsAntibacterial targetsBacterial cell envelope components

Inhibition of cell wall peptidoglycan cross-linking, inhibition of the 30S or 50S ribosomal subunits to prevent protein synthesis, inhibition of DNA gyrase and topoisomerase IV to prevent DNA replication, and disruption of bacterial membrane potential.